Related references
Note: Only part of the references are listed.The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils
Rebecca E. Nordquist et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Neurokinin-3 peptide instead of neurokinin-1 synergistically exacerbates kainic acid-inducing degeneration of neurons in the substantia nigra of mice
Liang-Wei Chen et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease
Xiaoqun Zhang et al.
NEUROPHARMACOLOGY (2008)
Substance P provides neuroprotection in cerebellar granule cells through Akt and MAPK/Erk activation: Evidence for the involvement of the delayed rectifier potassium current
G. Amadoro et al.
NEUROPHARMACOLOGY (2007)
Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons
C. Centeno et al.
CELL DEATH AND DIFFERENTIATION (2007)
JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species
HM Shen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism
B Salthun-Lassalle et al.
MOLECULAR PHARMACOLOGY (2005)
Differential co-localization of neurokinin-3 receptor and NMDA/AMPA receptor subunits in neurons of the substantia nigra of C57/BL mice
YQ Wang et al.
BRAIN RESEARCH (2005)
Specific pathophysiological functions of JNK isoforms in the brain
S Brecht et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease
LW Chen et al.
CURRENT DRUG TARGETS (2004)
Calcium-mediated activation of c-jun NH2-terminal kinase (JNK) and apoptosis in response to cadmium in murine macrophages
J Kim et al.
TOXICOLOGICAL SCIENCES (2004)
Substance P protects spiral ganglion neurons from apoptosis via PKC-Ca2+-MAPK/ERK pathways
F Lallemend et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity
M Arundine et al.
CELL CALCIUM (2003)
The role of c-jun N-terminal kinase (JNK) in Parkinson's disease
J Peng et al.
IUBMB LIFE (2003)
The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications
JM Loftis et al.
PHARMACOLOGY & THERAPEUTICS (2003)
A tachykinin-like factor increases glutamate toxicity in rat cerebellar granule cells
C Severini et al.
NEUROPHARMACOLOGY (2003)
The tachykinin peptide family
C Severini et al.
PHARMACOLOGICAL REVIEWS (2002)
AP-1 as a regulator of cell life and death
E Shaulian et al.
NATURE CELL BIOLOGY (2002)
Experimental models of Parkinson's disease
MF Beal
NATURE REVIEWS NEUROSCIENCE (2001)
Detailed distribution of neurokinin 3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study
X Langlois et al.
NEUROPHARMACOLOGY (2001)
Principles of tachykininergic co-transmission in the peripheral and enteric nervous system
CA Maggi
REGULATORY PEPTIDES (2000)
Functional changes of the basal ganglia circuitry in Parkinson's disease
F Blandini et al.
PROGRESS IN NEUROBIOLOGY (2000)
Share Paper
